Antimicrobial Agents and Resistance
The Antimicrobial Agents and Resistance (AAR) track features the latest on the discovery and development of new antimicrobial drugs in the pipeline, and their associated resistance mechanisms. The AAR track focuses on a broad range of topics, including surveillance and global epidemiology, mechanisms of resistance, antimicrobial discovery from pre-clinical investigations to post-marketing data, stewardship, novel approaches to infection diagnosis and treatment and pharmacokinetic/pharmacodynamic principles to optimize antimicrobial design and use.
Subtracks
-
Surveillance of Antimicrobial Resistance in Clinical Isolates: Molecular Typing and Molecular Epidemiology
AAR01
-
Antibiotic Agents: Mechanisms of Action and Resistance
AAR02
-
Antifungal Agents: Mechanisms of Action and Resistance
AAR03
-
Antiviral Agents (including HIV Drugs): Mechanisms of Action and Resistance
AAR04
-
Antimicrobial Stewardship
AAR05
-
Novel Approaches: Diagnostics/Discovery and Non-Traditional Therapies to Combat Drug-Resistant Infections
AAR06
-
Antimicrobial Pharmacokinetics and Pharmacodynamics
AAR07
-
New Antimicrobial Agents (in vitro and in vivo Studies)
AAR08
-
Antimicrobial Properties of Plants and Natural Products
AAR09